{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-008358","form_type":"8-K","ticker":"KURA","cik":"0001422143","company_name":"Kura Oncology, Inc.","filed_at":"2023-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.873063+00:00","generated_at":"2026-06-20T15:15:49.572109+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kura Oncology CCO Kirsten Flowers resigns; separation agreement provides 6 months salary + 2022 bonus","bullets":["Kirsten Flowers resigns as Chief Commercial Officer effective Jan 27, 2023.","Separation agreement provides 6 months base salary and 2022 annual cash bonus (discretionary).","Flowers agrees to a 6-month non-compete period following separation.","No successor named; search for replacement is ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-008358","json":"https://secwatch.observer/filing/0001193125-23-008358.json","markdown":"https://secwatch.observer/filing/0001193125-23-008358.md","text":"https://secwatch.observer/filing/0001193125-23-008358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/0001193125-23-008358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/d381827d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T15:15:49.572109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e51b12590e","claim":"Kirsten Flowers resigned as Chief Commercial Officer at Kura Oncology, Inc..","evidence_excerpt":"On January 10, 2023, Kirsten Flowers notified Kura Oncology, Inc. (the “Company”) of her intention to resign from her position as the Company’s Chief Commercial Officer, effective as of January 27, 2023 (the “Separation Date”), in order to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312523008358/0001193125-23-008358-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}